The effect of Sema3B on the modulation of M1 (CD80, CD86 and HLA-DR) and M2 (CD163 and CD206) surface markers expressed by RA synovial macrophages was also evaluated (6). This evidence concerns the gene CD86 and rheumatoid arthritis.